HK1249848A1 - 親脂性物質的水溶液，特別是藥物物質溶液 - Google Patents

親脂性物質的水溶液，特別是藥物物質溶液

Info

Publication number
HK1249848A1
HK1249848A1 HK18109260.4A HK18109260A HK1249848A1 HK 1249848 A1 HK1249848 A1 HK 1249848A1 HK 18109260 A HK18109260 A HK 18109260A HK 1249848 A1 HK1249848 A1 HK 1249848A1
Authority
HK
Hong Kong
Prior art keywords
solutions
lipophilic substances
particular medicinal
aqueous solutions
aqueous
Prior art date
Application number
HK18109260.4A
Other languages
English (en)
Inventor
C‧魯斯徹曼
A‧格普夫里奇
Original Assignee
雷根斯堡大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 雷根斯堡大學 filed Critical 雷根斯堡大學
Publication of HK1249848A1 publication Critical patent/HK1249848A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18109260.4A 2011-07-29 2018-07-17 親脂性物質的水溶液，特別是藥物物質溶液 HK1249848A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102011108948A DE102011108948A1 (de) 2011-07-29 2011-07-29 Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen

Publications (1)

Publication Number Publication Date
HK1249848A1 true HK1249848A1 (zh) 2018-11-16

Family

ID=46601818

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109260.4A HK1249848A1 (zh) 2011-07-29 2018-07-17 親脂性物質的水溶液，特別是藥物物質溶液

Country Status (7)

Country Link
EP (1) EP2736485B1 (zh)
CN (2) CN108042486A (zh)
DE (1) DE102011108948A1 (zh)
ES (1) ES2758711T3 (zh)
HK (1) HK1249848A1 (zh)
PL (1) PL2736485T3 (zh)
WO (1) WO2013017571A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108619118A (zh) * 2018-04-16 2018-10-09 郭丽颖 一种肺部吸入用布地奈德自组装胶束
EP3804740A1 (en) 2019-10-11 2021-04-14 TAPROGGE GmbH Compositions of the olea europaea v. sylvestris with antimicrobial efficacy
CN112294761A (zh) * 2020-09-29 2021-02-02 艾威药业(珠海)有限公司 一种难溶性药物的眼用胶束制剂

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3631490B2 (ja) * 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
WO1994004155A1 (en) * 1992-08-19 1994-03-03 Health Resource Institute, Ltd. Dehydroepiandrosterone therapy for the treatment of eye disorders
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
SE9704833D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New formulation
DE19810655A1 (de) 1998-03-12 1999-09-16 Univ Eberhard Karls Arzneimittel mit einem Gehalt an Ciclosporin
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
DE19930729A1 (de) 1999-07-05 2001-01-11 Achim Goepferich Blockcopolymere zur Herstellung biomimetischer Oberflächen
EP1759702B1 (en) * 2004-05-26 2009-01-07 Arturo Jimenez Bayardo Method of preparing a latanoprost ophthalmic solution and solution thus produced
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
CA2635797C (en) * 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
CN101420974A (zh) * 2006-02-15 2009-04-29 蒂卡莱克梅德尔公司 皮质类固醇溶液的制备方法
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
WO2009088570A1 (en) * 2008-01-04 2009-07-16 Sirion Therapeutics, Inc. Stable aqueous cyclosporin compositions
US20100030546A1 (en) 2008-07-29 2010-02-04 Freescale Semiconductor, Inc. Gui-facilitated simulation and verification for vehicle electrical/electronic architecture design
DE102008059201A1 (de) 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
US20100305046A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Stable cyclosporine containing ophthalmic emulsion for treating dry eyes

Also Published As

Publication number Publication date
ES2758711T3 (es) 2020-05-06
EP2736485A1 (de) 2014-06-04
CN103747780A (zh) 2014-04-23
DE102011108948A1 (de) 2013-01-31
WO2013017571A1 (de) 2013-02-07
EP2736485B1 (de) 2019-08-28
CN108042486A (zh) 2018-05-18
PL2736485T3 (pl) 2020-04-30

Similar Documents

Publication Publication Date Title
HK1255428A1 (zh) 包含納洛酮的鼻內藥物劑型
IL231382A0 (en) History of benzonitriles, their preparation containing them
EP2881395A4 (en) PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT
EP2809742A4 (en) CELLULOSE NANOWHISKERS IN DRILLING SERVICES
IL231386A (en) Pyrazolequinoline derivatives, their preparation and medical use
SG10201604667YA (en) Pharmaceutical preparation
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
AP2013006989A0 (en) 9-Ä4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxyÜ-1,4-diazaspiroÄ5,5Üundecane-5-one dimaleate, use thereof as a drug, and productionthereof
HK1210589A1 (zh) 水性液劑
HK1198939A1 (zh) 包含 和取代的β-環糊精的藥物製劑
ZA201405797B (en) Pharmaceutical dosage form
AP2015008208A0 (en) Pharmaceutical administration forms comprising
GB201105298D0 (en) Pharmaceutical preparation
HK1249848A1 (zh) 親脂性物質的水溶液，特別是藥物物質溶液
PL2734192T3 (pl) Musująca postać dawkowana
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
GB2525835B (en) Pharmaceutical agent
IL233238A (en) Sulphonylaminopyrrolidinone derivatives, their preparation and therapeutic use
PL2691119T3 (pl) Preparat farmaceutyczny
GB201112578D0 (en) Pharmaceutical preparation and use
IL232939A0 (en) Stable aqueous solutions of nitrogen monoxide, methods for their preparation and their uses
ZA201502354B (en) Pharmaceutical dosage form
PL398414A1 (pl) Zastosowanie kwas fenylo-1,4-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym
PL398411A1 (pl) Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym
GB201108234D0 (en) Pharmaceutical agent